Newstral
Article
seattletimes.com on 2021-02-04 16:15
Seattle startup Sana Biotech prices big stock offering
Related news
- Seattle-based biotech startup Sana raises $821 millionSeattle Times
- Seattle biotech Silverback Therapeutics prices upsized IPOseattletimes.com
- Seattle biotech PhaseRx prices IPO at $5 a shareseattletimes.com
- Seattle biotech startup Nautilus to get $350 million, stock listing in blank-check dealSeattle Times
- Seattle biotech startup Lumen Bioscience raises $11.2M to develop drugs using algae - Tue, 05 Dec 2017 PSTThe Spokesman-Review
- Seattle biotech PhaseRx files to go publicseattletimes.com
- Seattle Genetics buys biotech factory in Bothellseattletimes.com
- Seattle biotech Adaptive buys San Francisco firmseattletimes.com
- Seattle biotech startup aims for ‘new paradigm’ in medicine by parsing proteinsMerced Sun-Star
- Tech Spotlight: Seattle biotech startup Silene draws blood to help people invest in a healthy futureseattletimes.com
- Premium investment: Independent Health backs a biotech startup out of Seattlebizjournals.com
- Hearing loss biotech Decibel in trial mode after deal with Seattle startupbizjournals.com
- Seattle biotech stalwart ZymoGenetics prepares for year-end closureSeattle Times
- Seattle biotech firm Silverback Therapeutics aims for $100M IPOSeattle Times
- Promising COVID-19 treatment sends Seattle biotech company’s stock soaringSeattle Times
- At Seattle biotech Acucela, acrimony breaks into openold.seattletimes.com
- Google invests in Seattle clean energy startupSeattle Times
- Seattle health-data startup Truveta raises $95MSeattle Times